Monday, March 02, 2009 2:48:38 PM
I dont look at anything day-to-day. And I dont do "stops" just an amateur. Any sophistication stops at calls/puts.
Realistically, painful though it may be (sub $3 now) I would dump IDIX and put my money elsewhere. Their one drug Tyzeka is the ultimate commercial dog, and it really has an extraordinarily shallow pipe-line.
Also the chances that Novartis will buy them is extremely low, when they have delivered so little.
There are plenty of other biotechs that will do well this year, I could name half-a-dozen.
"....on the biotech battle-field, you need some élan...."
Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • BLOZF • Mar 19, 2026 12:45 PM
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
